The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Patients suffering from malignancies in advanced stages often develop brain metastases, which limit both the life span and the quality of life. Therapy options for multiple brain metastases may vary and range from stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), chemotherapy, immunotherapy to palliative best supportive care. Especially the efficacy and toxicity of SRS compared to WBRT in patients with extensive brain metastases (\>4) is not yet clear but of incremental relevance in this seriously ill cohort with a limited life span. These health-impaired patients might especi

Trial Details

NCT ID
NCT05378633
Phase
NA
Sponsor
University Hospital Heidelberg
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • SRS
  • Whole Brain Radiotherapy
Locations (sample)
  • Heidelberg, Germany|49.40768,8.69079

Key Eligibility Criteria

  • histologically confirmed malignant illness
  • 4-15 suspect intracranial lesions, taking into consideration all available MRI series
  • age ≥ 18 years of age
  • For women with childbearing potential, (and men) adequate contraception.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →